My research in emergent magneto-inductance phenomena and its applications in advanced sensing technology represents a significant step toward transformative breakthroughs. We are confident that this research will not only extend the boundaries of knowledge but also drive innovation in industries reliant on magnetic sensors. With the support of the JST-SPRING funding, we aim to make pioneering strides in this critical field, including achieving the optimization of magneto-inductance effect for practical applications through advanced nanofabrication and characterization techniques.

As a researcher, I desired to contribute to the field of health care through early diagnostics. Hence, I’m committed to developing clinical diagnostic devices for point-of-care testing so far. However, in terms of rare diseases, chronic diseases or new diseases, therapeutic methods appear to be more particularly important. I would like to start my career in Research and Development(R&D) position within pharmaceutical company, with my expertise in analytical techniques, instrumentations and data processing is vital for identifying, ensuring product quality or statistics. In addition, my experience on designing overall experimental plan will be helpful to find opportunities for designing analytical methods, troubleshooting and optimizing processes.This field offers dynamic challenges, professional growth, and the chance to make significant contributions to healthcare through groundbreaking pharmaceutical advancements.

In my research field, I am focusing on soft X ray absorption spectroscopy for studying the surface reaction mechanism. Recently new SXAS technic for measurement of liquid-solid interphase was been tested and needed to be further investigated. In long time, due to the short mean free path of electron in the liquid materials, XAS can be only detected by the fluorescence technic which give the bulk information. New technic for liquid environment XAS measurement can give us solid-liquid interphase surface information, which can help us further understand the liquid phase heterogeneous reaction mechanism. In this future, I want to continue the research on SXAS technics which can be a promising tool to understand unknow chemical reaction mechanism to help other researchers to develop more efficient catalysts.

I believe the focus of quantum computing will gradually shift from physical implementation to software development. Just like the evolution of classical computing, once the transistor-based computer design is established, it follows Moore’s law and evolves steadily, allowing software developers to invent many interesting applications. Now as the hardware design of quantum processors rapidly takes shape, we better start early to outline the blueprint of future quantum applications and use cases. Therefore, my research will focus on helping future computer scientists work with quantum computers more easily.

研究：これまでの専門である非線形化学に加え、AI、生物工学、ソフトロボティクス、非線形物理学に関する知識や技術を習得し、より複雑で生命に近い自己組織化現象にアプローチしたい。
キャリア：専門外の分野を勉強し複合領域的な研究を考案することが大きなモチベーションになっているので、今後もそういった挑戦をしていきたい。 また、海外でキャリアを積むことに興味があるため、国際的な経験や人脈作りをしていきたい。

現在の研究では，高張力鋼を中心に最先端材料に焦点を当て，将来的には金属に限らない広範なナノ材料や半導体関連の研究に進展する意向である．将来的には，学術研究と産業界との連携を一層強化し，国際的な視野で最先端の材料研究に取り組むことで，両国の産業界や学術界との相互の発展に貢献したいと考えている．異なる環境での経験を通して，国際社会で活躍する一翼を担うことが目標である．

My research is a study of modeling algorithms for recommender systems. I am currently creating an H-PLE model with higher performance and interpretability based on multitasking. My future career plan is to join a tech company like Google or Alibaba and work on related algorithms.

2023年度，Keio-SPRINGのプロジェクトを活用して，米国のカーネギーメロン大学に1年間Research Associateとして滞在しました．滞在中は現地の学生と共に研究を行い，研究に対する姿勢や，研究の進め方など，日本とは異なる部分が多くあり，非常に有意義な時間を過ごすことができました．今後はこの経験を自身の研究に活かし，さらに後輩にも伝えていきたいと思っています．

Galacto-oligosaccharides (GOS) is composed of a chain of 1~n galactose units with a sucrose terminal unit, which has many useful biological activities, especially immune activity. However, it is still difficult to total synthesis of GOS. In this year, I successfully accomplished stereoselective synthesis of α-GOS (n=1~8) with boron-mediated aglycon delivery (BMAD) method, which is developed in our lab for the stereoselective synthesis of 1,2-cis glycosides. The most effective α-GOS found in the evaluations will be used as lead compounds for vaccine adjuvants to stimulate human immunity and for therapeutic agents in the future.